Empatica

🎉 We’re thrilled to announce Empatica’s partnership with the global clinical research organization Allucent to support their award with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). We’ll be assisting Allucent with PROJECT REMOTE, a decentralized phase IV home focus COVID-19 vaccine trial funded under Project NextGen, an initiative by HHS to advance the next generation of vaccines, therapeutics, and enabling technologies. Allucent will use the EmbracePlus wearable and Empatica Health Monitoring Platform to collect continuous, real-time physiological data from 4,000 participants. In the words of Empatica’s CEO and Co-founder, Matteo Lai, “We are honored to contribute our technology to this critical initiative. Our previous collaborations with BARDA have already led to significant advancements, such as developing and validating an algorithm that predicts respiratory infections during the pandemic. We look forward to continuing our support of public health emergency preparedness efforts through this initiative, and to leveraging our digital health technologies to advance scientific knowledge and support development of new medical products”. Read the press release: https://lnkd.in/dn3hXw4H #WearableTechnology #DigitalBiomarkers

🚀 At Empatica, we’re committed to delivering safe, effective, and high-quality hardware and software that meet the needs of trial sponsors and CROs, as well as regulatory requirements. ✅ Empatica’s EmbracePlus, Care App, and Care Portal for clinical trials are CE certified and FDA-cleared. The FDA-clearance is crucial as it assures the safety and reliability of our products, representing a higher standard than other off-the-shelf commercial wearables available. Visit our website for more information on our quality management system: https://lnkd.in/dmKHamcC

⌚ EmbracePlus was selected for an analog space mission due to its EDA sensor, continuous health monitoring, easily accessible data, the platform’s FDA clearance, and the device's design. Jas P., research scientist and crew member of Analog Missions, said, “No doubt devices like EmbracePlus have a place in space missions: they provide an easy way of continuously monitoring the crew’s health." Read the full case study: https://lnkd.in/d-KuqXYe #WearableTechnology #DigitalBiomarkers 

Are you considering the use of digital endpoints in your next #ClinicalTrial to asses the impact of obesity treatments on patients? Download our free white paper and discover how you can integrate digital endpoints in your work on #Obesity management, and which measures are key to consider. What you’ll discover: ✅ The Obesity Epidemic: Current Trends and New Solutions ✅ The Role of Digital Health Technologies in Obesity Clinical Research ✅ Integrating Digital Endpoints in Obesity Management Download now: https://lnkd.in/dcxV4NR4 #WearableTechnology #DigitalBiomarkers 

Are you planning or running a clinical trial with wearables? #WearableTechnology offers a way to continuously and objectively collect data without the need for frequent site visits, easily fitting into patients’ day-to-day lives. Take part in our poll to let us know which form factor suits your clinical trials best. 

⌚💻 Are you an academic researcher considering the Empatica Health Monitoring Platform for your next study? Now, you can easily get a personalized quote directly from our website. Simply go to the Professional store, and enter your shipping, billing, and payment information. ➡️ Get your quote today: https://lnkd.in/dD_sU7pU #DigitalBiomarkers #WearableTechnology #AcademicResearch #ResearchStudies 

💻 Did you know that with Empatica’s #CloudAPI CROs and #ClinicalTrial sponsors can now run trials inside their own software infrastructure, using the EmbracePlus wearable, Empatica Health Monitoring Platform, and 200+ digital measures? With EmbracePlus, benefit from: ✅ An FDA-cleared medical wearable, with accuracy you can trust ✅ A modular design, to fit the needs of your study ✅ Up to 14 days battery life, keeping participants charged for longer ✅ Seamless participant ID integration, so participants can be onboarded and monitored using the same identifier Discover the Cloud API: https://lnkd.in/dPx5Yh5h #DigitalBiomarkers #WearableTechnology

Our Chief Scientist, Dr. Rosalind Picard, will be speaking at the 18th Annual Pain Therapeutics Summit in Boston. 📅 Join the panel session ‘Pain Biomarkers: Advancing Pain Therapeutics Development, Clinical Trials, and Patient Care’ at 3:30pm on Monday, October 28th. View the full agenda here: https://lnkd.in/dMvpzzpu 

Hypoglycaemia, a common complication for those with type 1 #diabetes, can be especially dangerous when driving. This study aimed to investigate machine learning based hypoglycaemia detection using wearable data at different levels of hypoglycaemia during a complex driving task. ⌚Using Empatica’s #WearableTechnology, electrodermal activity data was collected from participants aged 21-50. 🚗 During a controlled hypoglycaemia procedure, participants drove a simulator while wearing the device, and their blood glucose levels were measured to build and test the machine learning model. 📈 The main outcome of the analysis was the diagnostic accuracy of the machine learning approach to detect hypoglycaemia. Read in full: https://lnkd.in/dfUFNvAj #DigitalBiomarkers Martin Maritsch Wiley

Are you planning a #ClinicalTrial focused on pain? Download our free white paper to discover how integrating wearable devices and digital endpoints in your research can improve participation and reduce the reliance on subjective self-reporting methods. The white paper covers: 1️⃣ Evolving approaches in pain management 2️⃣ The contribution of Digital Health Technologies (DHTs) and wearables in pain research 3️⃣ Integrating digital endpoints in monitoring and quantifying pain Download today: https://lnkd.in/dtFK2EhN #WearableTechnology #DigitalBiomarkers #PainResearch